NCT04473911 2025-07-20Haplo Peripheral Blood Sct In GVHD PreventionMassachusetts General HospitalPhase 1 Completed25 enrolled
NCT06815003 2025-06-27Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningCity of Hope Medical CenterPhase 2 Recruiting35 enrolled
NCT00544115 2025-06-10Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical CenterPhase 2 Active not recruiting260 enrolled 13 charts
NCT06996119 2025-05-30Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantCity of Hope Medical CenterPhase 1 Not yet recruiting15 enrolled